Tiziana Life Sciences Ltd Cash Flow-to-Debt Ratio
Tiziana Life Sciences Ltd cash flow-to-debt ratio. Tiziana Life Sciences Ltd (TLSA) has a Cash Flow-to-Debt Ratio of -0.53x as of March 2026, meaning its operating cash flow of $-6.02 Million could theoretically repay -1% of its total liabilities ($11.44 Million) in one year. See Tiziana Life Sciences Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Tiziana Life Sciences Ltd (1998–2025)
Cash flow-to-debt ratio of Tiziana Life Sciences Ltd from 1998 to 2025. Historical debt coverage capacity for Tiziana Life Sciences Ltd across 28 annual periods. Check TLSA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Tiziana Life Sciences Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Tiziana Life Sciences Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Tiziana Life Sciences Ltd. For the full cash flow conversion analysis, see Tiziana Life Sciences Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.12x | $-12.85 Million | $11.44 Million | ▼ -576.5% |
| 2024 | -0.17x | $-1.22 Million | $7.35 Million | ▲ +91.1% |
| 2023 | -1.87x | $-12.42 Million | $6.65 Million | ▲ +19.3% |
| 2022 | -2.32x | $-15.99 Million | $6.91 Million | ▼ -8.3% |
| 2021 | -2.14x | $-16.13 Million | $7.55 Million | ▼ -101.9% |
| 2020 | -1.06x | $-8.76 Million | $8.27 Million | ▼ -19.8% |
| 2019 | -0.88x | $-5.29 Million | $5.99 Million | ▼ -22.8% |
| 2018 | -0.72x | $-3.63 Million | $5.04 Million | ▲ +55.5% |
| 2017 | -1.62x | $-5.68 Million | $3.51 Million | ▲ +50.0% |
| 2016 | -3.23x | $-5.62 Million | $1.74 Million | ▲ +57.7% |
| 2015 | -7.64x | $-5.70 Million | $746.00K | ▼ -125.5% |
| 2014 | -3.39x | $-2.31 Million | $683.00K | ▼ -848.4% |
| 2013 | -0.36x | $-97.13K | $272.00K | ▲ +78.7% |
| 2012 | -1.68x | $-227.89K | $136.00K | ▲ +81.0% |
| 2011 | -8.82x | $-881.91K | $100.00K | ▼ -799.5% |
| 2010 | -0.98x | $-407.86K | $416.00K | ▲ +5.3% |
| 2009 | -1.04x | $-535.42K | $517.00K | ▲ +30.8% |
| 2008 | -1.50x | $-959.80K | $641.00K | ▲ +67.8% |
| 2007 | -4.65x | $-2.15 Million | $462.00K | ▼ -73.5% |
| 2006 | -2.68x | $-1.96 Million | $732.00K | ▼ -40.0% |
| 2005 | -1.92x | $-1.18 Million | $618.00K | ▲ +33.1% |
| 2004 | -2.86x | $-1.72 Million | $601.00K | ▲ +47.0% |
| 2003 | -5.40x | $-1.52 Million | $282.00K | ▼ -23.5% |
| 2002 | -4.38x | $-1.57 Million | $359.00K | ▲ +35.3% |
| 2001 | -6.77x | $-2.46 Million | $363.00K | ▼ -52.1% |
| 2000 | -4.45x | $-2.19 Million | $493.00K | ▼ -208.9% |
| 1999 | -1.44x | $-527.00K | $366.00K | ▼ -94.6% |
| 1998 | -0.74x | $-310.00K | $419.00K | — |